Global coronavirus cases have surpassed 200,000 Wednesday morning and more than 8,200 have lost their lives since a novel virus appeared in the Hubei province of China late last year.
According to a tally kept by Johns Hopkins University, more than 82,000 people have recovered from the virus.
As of 9 a.m. Wednesday, China tops the list with 81,102 cases, Italy has the second-highest number of cases with 31,506 and Iran comes next with 17,361.
All 50 states in the U.S. are now linked to the virus, with nearly 6,500 confirmed cases around the nation. West Virginia was the last state to report a coronavirus case Tuesday afternoon.
At least 100 people have died in the U.S., linked to the virus’s outbreak. Thirty of those individuals are linked to the Life Care Center in Kirkland, Wash., one of the first hotspots of community spread in the nation.
As test production ramps up around the nation, those numbers are expected to rise.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
